|
The
Conway Institute for Biomolecular and Biomedical Research was
opened by An Tánaiste, Mary Harney TD, on 11 September. The
€90 million research facility will serve as a national resource
for researchers to create knowledge that enhances Ireland's
position in medical and scientific research.

Dr
Dorothy McGeeney, daughter of Professor Edward Joseph Conway,
makes a presentation to An Tánaiste, Mary Harney TD, at the
official opening of the Conway Institute, observed by Cllr Trevor
Matthews, Cathaoirleach of Dun Laoghaire-Rathdown County
Council.
The
Institute is a multi-disciplinary centre named after Professor E
J Conway, who held the first Chair of Biochemistry and
Pharmacology in UCD. Its mission is to promote knowledge, health
and economic advancement through excellence in biomolecular and
biomedical sciences.
The
11,300 sq m facility will provide a research environment to
advance the treatment of diseases such as cancer, diabetes,
Alzheimer's, heart disease and arthritis. Developing research networks
encompassing other leading universities, the Institute will also
provide a crucial infrastructure to increase the attractiveness
of Ireland as a base for research and development in
biotechnology and related industries.
Speaking
at the opening ceremony, the President, Dr Cosgrove, said Science
is a public activity, supported by public and charitable funds and
conducted in public trust. "The present state and future
development of science depends upon the ongoing support of the
people, through their Government," he said. "This is an
appropriate time, as we see vision translated into reality, to
recognise the leadership and support offered by you, Tánaiste,
and others in public life. We in turn are committed to maximising
the return on this unprecedented investment, generating a social
and economic dividend in health, education and the growth of knowledge-based
bio-industry."
The
building was funded in partnership between the Higher Education
Authority and Atlantic Philanthropies, under the Programme for Research
in Third-level Institutions, and Dr Cosgrove acknowledged the
continuing commitment of the State and the donor to creating
a research infrastructure, which will allow Irish science to have
global impact. "You will see that our researchers not only
have laboratories fitted and equipped to the highest standards,
they also have a dynamic and exciting place to work," he
said.
The
Tánaiste described the Institute as 'a key infrastructural
investment in the Life Sciences/Biotechnology sector. "It is
part of the infrastructure needed in delivering Ireland's strategic
objective of developing world class competence and businesses
built around these technologies," she said. Denis
Brosnan, Chair of the Conway Board of Management, said the
Institute will be internationally recognised as an important
centre for research in several key areas. "It will have a reputation
for excellence in teaching and training," he said. "It
will form close and productive relationships with industry and
will be acknowledged by the public as an important contributor
to our social economic development."
Dr
Philip Nolan, Director of the Institute, said the investment will
play 'a crucial role' in shaping Ireland's social and economic
future in terms of science, health, education and the growth of a knowledge
economy.
|